1.Date of occurrence of the change:2026/05/27
2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):Institutional director、independent director and natural-person director
3.Title and name of the previous position holder:
(1)Director:Representative of TTY Biopharm Company Limited:Chuan Lin
(2)Director:Representative of TTY Biopharm Company Limited:Carl Hsiao
(3)Director:Representative of TTY Biopharm Company Limited:Kang-Chi Chou
(4)Director:Representative of TTY Biopharm Company Limited:Yong-Liang Wu
(5)Independent Director:Te-Yu Chou
(6)Independent Director:Rwei-Syun Chen
(7)Independent Director:Yaw-Bin Huang
(8)Independent Director:Shiow-Ming Wu
(9)Independent Director:Yuen-Liang Lai
4.Resume of the previous position holder:
(1)Chuan Lin:Chairman of TTY Biopharm Company Limited
(2)Carl Hsiao:Director of TTY Biopharm Company Limited
(3)Kang-Chi Chou:Chairman of BaaS Innovation Co., Ltd.
(4)Yong-Liang Wu:Supervisor of Dawan Technology Co., Ltd.
(5)Te-Yu Chou:Independent Director of Taiwan Cooperative Bank
(6)Rwei-Syun Chen:Independent Director of GENERAL BIOLOGICALS CORP.
(7)Yaw-Bin Huang:Professor of School of Pharmacy, Kaohsiung Medical University
(8)Shiow-Ming Wu:Adjunct Professor of Department of Land Economics, National Chengchi University
(9)Yuen-Liang Lai:Honorary Consultant Physician, MacKay Memorial Hospital
5.Title and name of the new position holder:
(1)Director:Representative of TTY Biopharm Company Limited:Chuan Lin
(2)Director:Representative of TTY Biopharm Company Limited:Carl Hsiao
(3)Director:Representative of TTY Biopharm Company Limited:Kang-Chi Chou
(4)Director:Duei Tsai
(5)Director:Representative of TTY Biopharm Company Limited:Yong-Liang Wu
(6)Independent Director:Yaw-Bin Huang
(7)Independent Director:Te-Yu Chou
(8)Independent Director:Shiow-Ming Wu
(9)Independent Director:Yuen-Liang La
6.Resume of the new position holder:
(1)Chuan Lin:Chairman of TTY Biopharm Company Limited
(2)Carl Hsiao:Director of TTY Biopharm Company Limited
(3)Kang-Chi Chou:Chairman of BaaS Innovation Co., Ltd.
(4)Duei Tsai:Independent Director of Taiwan High Speed Rail Corporation
(5)Yong-Liang Wu:Supervisor of Dawan Technology Co., Ltd.
(6)Yaw-Bin Huang:Professor of School of Pharmacy, Kaohsiung Medical University
(7)Te-Yu Chou:Independent Director of Taiwan Cooperative Bank
(8)Shiow-Ming Wu:Adjunct Professor of Department of Land Economics, National Chengchi University
(9)Yuen-Liang Lai:Honorary Consultant Physician, MacKay Memorial Hospital
7.Circumstances of change (Please enter “resignation”, “dismissal”,“term expired”, “death” or “new appointment”): Term expired
8.Reason for the change:Re-election of the Board of Directors
9.Number of shares held by the new position holder when elected:
(1)Director:TTY Biopharm Company Limited(Representative:Chuan Lin); 21,687,177 shares
(2)Director:TTY Biopharm Company Limited(Representative:Carl Hsiao); 21,687,177 shares
(3)Director:TTY Biopharm Company Limited(Representative:Kang-Chi Chou); 21,687,177 shares
(4)Director:Duei Tsai;0 shares
(5)Director:TTY Biopharm Company Limited(Representative:Yong-Liang Wu); 21,687,177 shares
(6)Independent Director:Yaw-Bin Huang;0 shares
(7)Independent Director:Te-Yu Chou;0 shares
(8)Independent Director:Shiow-Ming Wu;0 shares
(9)Independent Director:Yuen-Liang Lai;0 shares
10.Original term (from __________ to __________):2023/05/25~2026/05/24
11.Effective date of the new appointment:2026/05/27
12.Turnover rate of directors of the same term:NA
13.Turnover rate of independent directors of the same term:NA
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter “Yes” or“No”):NA
16.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 6 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None


